
Precision in Practice: The Critical Role of Radiation Dosimetry in Radiotherapeutic Pharmaceuticals
Radiation dosimetry plays a critical role in the development and application of radiotherapeutic pharmaceuticals, ensuring both efficacy and safety in treatment. Accurate dosimetry enables precise quantification of the radiation dose delivered to target tissues, such as tumors, while minimizing exposure to surrounding healthy tissues. This precision is essential for maximizing therapeutic outcomes and reducing side effects. In the context of radiopharmaceuticals, dosimetry is particularly important because the distribution of radioactive agents can vary significantly depending on the patient’s physiology and the agent's pharmacokinetics. By providing detailed dose assessments, dosimetry supports the optimization of treatment protocols, individualizing therapy to meet patient-specific needs. Additionally, it aids in regulatory compliance by ensuring that the safety thresholds for radiation exposure are met during clinical trials and routine use. Advances in dosimetry technologies, including imaging-based approaches and computational modeling, further enhance our ability to assess dose distributions, contributing to the continued evolution of precision medicine in radiation therapy.
Topics:
- Precision in RPT Practice: The Critical Role of Radiation Dosimetry in Radiotherapeutic Pharmaceuticals and Advancing Dosimetry for Radiopharmaceuticals in Modern Nuclear Oncology
N. Calvin Han, MD - Radiation Dosimetry for Radiopharmaceuticals
Andrei H. Iagaru, MD - Computational Nuclear Oncology for Precision Radiopharmaceutical Therapies: Towards Theranostic Digital Twins for Patients
Arman Rahmim, PhD, DABSNM, FSNMMI - Q and A
N. Calvin Han, MD - Moderator
Full Panel
This activity is available from December 1, 2025, through 11:59 p.m. Eastern time on November 30, 2027.
The content was originally presented and recorded at the 2025 ASTRO Annual Meeting.
Target Audience
The activity is designed to meet the interests of medical oncologists, radiation oncologists, surgeons, physicists, diagnostic radiologists, radiation therapists, dosimetrists, radiation biologists and residents.
Learning Objectives
Upon completion of this activity, participants should be able to:
- Provide comprehensive training on modern dosimetric techniques to optimize radiopharmaceuticals efficacy while minimizing adverse effects.
- Highlight the integration of radiopharmaceuticals into multidisciplinary care plans, showcasing their potential in medical oncology, surgical oncology and radiation oncology.
Course summary
- 1.25 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
- N. Calvin Han, MD, is employed by the Food and Drug Administration.
- Andrei H. Iagaru, MD, is employed by Stanford University. Dr. Iagaru receives honoraria as a consultant from GE Healthcare, Lantheus, Eli Lilly and Novartis Pharmaceuticals.
- Arman Rahmim, PhD, is employed by University of British Columbia. Dr. Rahmim is co-founder and has ownership equity in Ascinta Technologies.
All relevant financial relationships have been mitigated.
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Available Credit
- 1.25 AMA PRA Category 1 Credit™
The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this Enduring material for a maximum of 1.25 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
- 1.25 Certificate of AttendanceThis activity was designated for 1.25 AMA PRA Category 1 Credit™.
Price
Activity Fees
This activity is included in the ASTRO Academy Subscription. To purchase the subscription beginning December 1, 2026, please go to the ASTRO Product Catalog.
ASTRO members and Academy subscribers must log in to the ASTRO Academy to view and receive the corresponding rate:
- Academy Subscriber: $0
- Member: $99
- Member-in-Training / Student Member / Postdoctoral Fellow Member: $49
- Nonmember: $149
Discounts
Please email ASTRO eLearning to inquire about the discounts below.
- If you are an ASTRO member residing in a low- or lower-middle-income economy country, as identified by the World Bank, you can receive a 50% discount off the activity fee.
- If you are an ASTRO member residing in an upper-middle-income economy country, as identified by the World Bank, you can receive a 25% discount off the activity fee.
Policies
No refunds, extensions, or substitutions will be made for those participants who, for any reason, have not completed the activity by the expiration date.
Participants using ASTRO Academy activities to satisfy the requirement of a Continuing Certification (MOC) program should verify the credit number and type and availability dates of any activity before making a purchase. No refunds, extensions, or substitutions will be made for participants who have purchased activities that do not align with their MOC requirement.
The activity and its materials will only be available on the ASTRO website until the Activity expiration date, regardless of purchase date. At the expiration of the activity, participants will no longer have access to the activity or its materials. ASTRO reserves the right to remove an activity before its expiration date.
Copyright of all aspects of ASTRO Academy Content, including recordings and/or reproductions of sessions, programs, presentations, discussions and other scheduled events (“ASTRO Academy Content”) is owned by ASTRO. Only ASTRO reserves the rights to all ASTRO Academy Content, including to digitize, modify, alter, edit, adapt, create derivative works, display, publicly perform, exhibit, transmit, broadcast, reproduce, exploit, sell, rent license, otherwise use, and permit others to use, such ASTRO Academy Content. Photographing, filming, taping, recording or any form of capture or reproduction in any medium of any aspect of ASTRO Academy Content, including, but not limited to the programs, presentations, material, sessions, and discussions, or on the Academy platform are strictly forbidden without written authorization from ASTRO.
Required Hardware/software
One of the two latest versions of Google Chrome, Mozilla Firefox, Internet Explorer or Safari.

Facebook
X
LinkedIn
Forward